Clinical Trials and CPD Regulation
Clinical trials
Clinical research in Bahrain is regulated to protect participants and ensure scientific validity. Candidates must understand the requirement for ethics committee review and NHRA approval before a trial begins, informed consent standards, investigator qualifications, safety reporting (adverse events and serious adverse events), protocol amendments, and record retention. Know the roles of the sponsor, investigator and institution, and the rules on vulnerable participants and conflicts of interest.
Continuing professional development
CPD is a condition of licence renewal. Understand how CPD credits are structured, the categories of acceptable activity (formal education, self-directed learning, practice-based learning, teaching and research), the required annual or cycle totals, and the documentation and audit process. Know that CPD must be relevant to the practitioner's scope of practice and that falsified records are a disciplinary matter.
Common traps
A frequent error is assuming ethics approval alone permits a trial to start - regulatory approval is also required. Another trap is confusing adverse-event reporting timelines for investigators versus sponsors. In CPD questions, watch for activities that are not creditable (routine work without reflective learning) and for the assumption that credits carry over indefinitely.
Rule of thumb
For trials: no approval, no recruitment. For CPD: relevance plus evidence - an activity counts only if it relates to your practice and is documented.